The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s deep vein thrombosis market report forecasts the deep vein thrombosis market size to grow to $1.20 Billion by 2027, with a CAGR (compound annual growth rate) of 4%.

Learn More On The Deep Vein Thrombosis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Deep Vein Thrombosis Market Size Forecast
The global deep vein thrombosis market is expected to grow from $0.98 billion in 2022 to $1.03 billion in 2023 at a compound annual growth rate (CAGR) of 4.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global deep vein thrombosis market size is expected to reach $1.20 billion in 2027 at a CAGR of 4.0%.

North America held the largest deep vein thrombosis market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Deep Vein Thrombosis Market Driver ­– Increase In Number Of Individuals Who Require Deep Vein Thrombosis Treatment
According to the Centres for Disease Control and Prevention (CDC), a US-based national public health agency, in February 2023, an estimated 900,000 people in the United States could be affected by deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). As a result, the market is being driven by the growing number of people who require deep vein thrombosis (DVT) treatment.

Request for A Sample Of The Global Deep Vein Thrombosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

Key Deep Vein Thrombosis Market Trend – Product Innovations
Major players in the deep vein thrombosis market are embracing new technologies in order to develop new products and maintain their market position. For example, Penumbra Inc., a US-based developer of new medicines, developed Lightning Flash in January 2023, an advanced and powerful mechanical thrombectomy system for treating venous and pulmonary thrombus. Penumbra’s revolutionary lightning-intelligent aspiration technology and innovative dual clot detection algorithms are used in the system. It is intended to remove big blood clots in the body fast, such as venous thrombus and pulmonary emboli (PE). It provides clinicians with a bigger, high torque-able catheter suited to remove a considerable clot burden in the pulmonary arteries or deep venous system while preserving a good safety profile.

Deep Vein Thrombosis Market Segment
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Deep Vein Thrombosis Market Major Players and Strategies
Major players in the deep vein thrombosis market are Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis, Daiichi Sankyo Company, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Momenta Pharmaceutical Inc., Hikma Pharmaceuticals PLC, Laboratorios Farmaceuticos Rovi SA, Cardinal Health, and Altimed Ltd.

Surmodics, a medical device and in-vitro diagnostic firm based in the United States, paid $39.9 million for Vetex Medical in July 2021. Surmodics’ plan to extend its thrombectomy portfolio and boost its position in the peripheral vascular sector includes this acquisition. Surmodics acquires access to the ClotTriever system as well as additional products in Vetex’s pipeline, including the Venous Solutions thrombectomy system, with the acquisition of Vetex Medical. Vetex Medical is an Irish medical device firm that specialises in the development of medical devices for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).

The Deep Vein Thrombosis Global Market Report 2023 covers regional data on deep vein thrombosis market size, deep vein thrombosis market trends and drivers, opportunities, strategies, and deep vein thrombosis market competitor analysis. The countries covered in the deep vein thrombosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Deep vein thrombosis (DVT) is a potentially fatal medical disorder that develops when a blood clot forms in one or more of the body’s deep veins. DVT symptoms include swelling, discomfort, and soreness in the afflicted location, which is commonly the leg.

View More Reports Related To The Deep Vein Thrombosis Market –
Deep Sea, Coastal, And Great Lakes Global Market Report 2023
Deep Learning Global Market Report 2023
Vein Illuminator Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: